Article Details

Ansun raises $85M in series A to fund phase 3 antiviral study

Retrieved on: 2018-05-14 00:18:45

Tags for this article:

Click the tags to see associated articles and topics

Ansun raises $85M in series A to fund phase 3 antiviral study. View article details on hiswai:

Excerpt

<div>... and included investments from Yuanming Capital, Lyfe Capital, Oceanpine Capital, VI Ventures, <b>Matrix Partners</b> China, 3e Bioventures Capital and ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo